Maryam Kashanian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Maryam Kashanian has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Narges Sheikhansari
University of Exeter Medical School
25 shared publications- Hamid Reza Baradaran
Department of Epidemiology, School of Public Health Iran University of Medical Sciences Tehran Iran
12 shared publications Shohreh Bahasadri
Iran University of Medical Sciences, Obstetrics & Gynecology, Tehran, Iran
10 shared publicationsNooshin Eshraghi
Department of Obstetrics and Gynecology, Akbarabadi Teaching Hospital, Iran University of Medical Sciences, Tehran, Iran
6 shared publicationsFarideh Dadkhah
A Department of Obstetrics & Gynecology , Iran University of Medical Sciences , Tehran , Iran
5 shared publicationsElaheh Sariri
4 shared publications
Latest Publications
- Open Access
- 11 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
When to conceive following metabolic-bariatric surgery to optimize both surgical weight loss and gestational weight gain
Most patients undergoing metabolic-bariatric surgery are women and half of them are at reproductive age. Although it is recommended delaying pregnancy after surgery, the optimal time to conceive yet remains controversial. This study aimed to define the best conception time following surgery to optimize both surgical weight loss and gestational weight gain. This cohort study included all women who gave birth after surgery recorded in the Iranian National Obesity Surgery Database during 2009-2023. First, weight loss pattern from surgery to pregnancy was addressed by curve fitting and univariate segmented relationship and then evaluated by regression model added with maternal and perinatal outcomes. Overall, 430 women with a mean age of 33.81 ± 4.70 years, entered the analysis. We revealed two change points of 4 and 13 months in weight loss trend from surgery to pregnancy. Accordingly, pregnancy within 4-13 and over 13 months was significantly associated with a higher mean of percent total weight loss (β = 13.35, 95%CI: 9.24, 17.46 and β = 14.32, 95%CI: 10.24, 18.40, respectively) and a lower risk of inadequate gestational weight gain (OR = 0.26, 95%CI: 0.09, 0.75 and OR = 0.12, CI: 0.04, 0.34, respectively) than pregnancy before 4 months following surgery. Pregnancy at least 13 months after metabolic-bariatric surgery is associated with greater surgical weight loss and a lower risk of inadequate gestational weight gain. Therefore, we recommend a broad guide of 12-18 months as the earliest time to plan for pregnancy after surgery.
- 11 July 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessWhen to conceive following metabolic-bariatric surgery to optimize both surgical weight loss and gestational weight gain
Most patients undergoing metabolic-bariatric surgery are women and half of them are at reproductive age. Although it is recommended delaying pregnancy after surgery, the optimal time to conceive yet remains controversial. This study aimed to define the best conception time following surgery to optimize both surgical weight loss and gestational weight gain. This cohort study included all women who gave birth after surgery recorded in the Iranian National Obesity Surgery Database during 2009-2023. First, weight loss pattern from surgery to pregnancy was addressed by curve fitting and univariate segmented relationship and then evaluated by regression model added with maternal and perinatal outcomes. Overall, 430 women with a mean age of 33.81 ± 4.70 years, entered the analysis. We revealed two change points of 4 and 13 months in weight loss trend from surgery to pregnancy. Accordingly, pregnancy within 4-13 and over 13 months was significantly associated with a higher mean of percent total weight loss (β = 13.35, 95%CI: 9.24, 17.46 and β = 14.32, 95%CI: 10.24, 18.40, respectively) and a lower risk of inadequate gestational weight gain (OR = 0.26, 95%CI: 0.09, 0.75 and OR = 0.12, CI: 0.04, 0.34, respectively) than pregnancy before 4 months following surgery. Pregnancy at least 13 months after metabolic-bariatric surgery is associated with greater surgical weight loss and a lower risk of inadequate gestational weight gain. Therefore, we recommend a broad guide of 12-18 months as the earliest time to plan for pregnancy after surgery.
- Open Access
- 27 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Maternal and neonatal outcomes after bariatric surgery in pregnancy: a cohort study comparing women with and without prior bariatric surgery
Pregnant women with obesity are at increased risk of adverse maternal and neonatal outcomes, including gestational diabetes and hypertensive disorders. Although bariatric surgery is an effective long-term treatment for obesity, its effects on pregnancy and postpartum outcomes remain incompletely understood. This retrospective cohort study aimed to evaluate the impact of bariatric surgery on maternal and neonatal outcomes. The study was conducted between May 2022 and January 2024 at national obesity and healthcare clinics and included 170 pregnant women, of whom 87 had a history of bariatric surgery and 83 had obesity without prior surgery. Data were collected using questionnaires, interviews, and labor records. Adjusted regression analyses were performed using SPSS version 22. After adjustment for potential confounders, pregnancies following bariatric surgery were associated with a higher risk of maternal anemia (P = .003) and a lower incidence of large for gestational age infants (P = .030). The surgical group also delivered at an earlier gestational age (P = .001) and had infants with lower birth weights (P = .049) than the controls group. No significant differences were found in oligohydramnios, polyhydramnios, pregnancy-induced hypertension, or hyperemesis gravidarum. Therefore, pregnancies in women with a history of bariatric surgery were associated with a higher risk of anemia, lower gestational age, and lower birth weight compared to women with obesity, but a lower incidence of delivering a large-for-gestational-age infant.
- 27 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMaternal and neonatal outcomes after bariatric surgery in pregnancy: a cohort study comparing women with and without prior bariatric surgery
Pregnant women with obesity are at increased risk of adverse maternal and neonatal outcomes, including gestational diabetes and hypertensive disorders. Although bariatric surgery is an effective long-term treatment for obesity, its effects on pregnancy and postpartum outcomes remain incompletely understood. This retrospective cohort study aimed to evaluate the impact of bariatric surgery on maternal and neonatal outcomes. The study was conducted between May 2022 and January 2024 at national obesity and healthcare clinics and included 170 pregnant women, of whom 87 had a history of bariatric surgery and 83 had obesity without prior surgery. Data were collected using questionnaires, interviews, and labor records. Adjusted regression analyses were performed using SPSS version 22. After adjustment for potential confounders, pregnancies following bariatric surgery were associated with a higher risk of maternal anemia (P = .003) and a lower incidence of large for gestational age infants (P = .030). The surgical group also delivered at an earlier gestational age (P = .001) and had infants with lower birth weights (P = .049) than the controls group. No significant differences were found in oligohydramnios, polyhydramnios, pregnancy-induced hypertension, or hyperemesis gravidarum. Therefore, pregnancies in women with a history of bariatric surgery were associated with a higher risk of anemia, lower gestational age, and lower birth weight compared to women with obesity, but a lower incidence of delivering a large-for-gestational-age infant.
- Open Access
- 30 March 2025
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 19 (1) , 50-61
Insights Into Bacterial Vaginosis During Pregnancy and Its Relationship with Preterm Birth: A Comprehensive Study in Shahid Akbarabadi Hospital, Tehran, Iran
Background and Aim: Bacterial Vaginosis (BV) is a common condition affecting women of reproductive age, including pregnant women. It involves a disruption of the microbial balance in the vaginal environment, which can lead to undesirable outcomes such as preterm birth. This study aimed to assess the incidence of BV and its relationship ...
- 30 March 2025
- Published by Farname, Inc. in Iranian Journal of Medical Microbiology
- Vol. 19 (1) , 50-61
Open AccessInsights Into Bacterial Vaginosis During Pregnancy and Its Relationship with Preterm Birth: A Comprehensive Study in Shahid Akbarabadi Hospital, Tehran, Iran
Background and Aim: Bacterial Vaginosis (BV) is a common condition affecting women of reproductive age, including pregnant women. It involves a disruption of the microbial balance in the vaginal environment, which can lead to undesirable outcomes such as preterm birth. This study aimed to assess the incidence of BV and its relationship ...
- 7 September 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (2) , 735-742
Risk factors and clinical features of pre‐eclampsia in Iranian and Afghan mothers: A comparative study
Objective: To assess variations in the presentation and clinical implications of pre‐eclampsia between Iranian and Afghan mothers at a maternity center in Tehran. Methods: We conducted a cross‐sectional study of Iranian and Afghan mothers diagnosed with pre‐eclampsia. Data were collected from March 2021 to February 2023 at a maternity center in Tehran, Iran. Demographic information, clinical characteristics, and laboratory findings were extracted from medical records. Statistical analyses were employed to compare differences between Iranian and Afghan mothers, including Mann–Whitney U , Pearson χ 2 tests, and logistic regression models. Results: We included 822 pregnant women with pre‐eclampsia, predominantly Iranian (75.5%) and Afghan (24.5%). Regarding the multivariate logistic regression model, Iranian mothers were older, with a higher proportion over 35 years. Although Afghan mothers showed higher gravidity counts and greater gestational ages at delivery, they had lower rates of hypothyroidism. Iranian women were more often categorized as obese than Afghan women, and the difference was statistically significant. Serum levels of alkaline phosphatase were significantly greater in Afghan women. Conclusion: Pre‐eclampsia poses significant maternal health risks, especially among Afghan refugees in Iran. Variances in age, gravidity, and hypothyroidism prevalence highlight the need for tailored healthcare strategies. Addressing cultural barriers and implementing targeted interventions can improve maternal and fetal outcomes in these populations.
- 7 September 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 168 (2) , 735-742
Risk factors and clinical features of pre‐eclampsia in Iranian and Afghan mothers: A comparative study
Objective: To assess variations in the presentation and clinical implications of pre‐eclampsia between Iranian and Afghan mothers at a maternity center in Tehran. Methods: We conducted a cross‐sectional study of Iranian and Afghan mothers diagnosed with pre‐eclampsia. Data were collected from March 2021 to February 2023 at a maternity center in Tehran, Iran. Demographic information, clinical characteristics, and laboratory findings were extracted from medical records. Statistical analyses were employed to compare differences between Iranian and Afghan mothers, including Mann–Whitney U , Pearson χ 2 tests, and logistic regression models. Results: We included 822 pregnant women with pre‐eclampsia, predominantly Iranian (75.5%) and Afghan (24.5%). Regarding the multivariate logistic regression model, Iranian mothers were older, with a higher proportion over 35 years. Although Afghan mothers showed higher gravidity counts and greater gestational ages at delivery, they had lower rates of hypothyroidism. Iranian women were more often categorized as obese than Afghan women, and the difference was statistically significant. Serum levels of alkaline phosphatase were significantly greater in Afghan women. Conclusion: Pre‐eclampsia poses significant maternal health risks, especially among Afghan refugees in Iran. Variances in age, gravidity, and hypothyroidism prevalence highlight the need for tailored healthcare strategies. Addressing cultural barriers and implementing targeted interventions can improve maternal and fetal outcomes in these populations.
- Open Access
- 13 March 2024
- Published by SCI AND TECH UNIVERSAL INC in Journal of Obstetrics, Gynecology and Cancer Research
- Vol. 9 (2) , 125-130
Comparison of Intravascular Versus Intramuscular Betamethasone Phosphate on Neonatal Outcomes in the Cases of Imminent Preterm Birth
Background & Objective: Preterm birth is the most important cause of neonatal mortality and morbidity. Finding the best treatment regimen, of antenatal corticosteroids, has been under serious concern. To compare the efficacy of intravascular versus intramuscular betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.Materials & Methods: A double-blind randomized clinical trial was performed on 136 eligible pregnant women with gestational age of 26- 34 weeks and imminent preterm birth (delivery within 24 hours). They were randomly assigned into two groups. Group A received intramuscular betamethasone phosphate, and group B received a similar dose of betamethasone phosphate intravenously. Women were followed up to delivery, and their neonatal outcomes were compared.Results: Women of the two groups (68 women in each group), did not show a significant difference in maternal age, BMI, gravidity and parity, gestational age at the time of admission and delivery, history of miscarriage and assisted reproductive techniques, delivery route, sex and weight of newborns, and Apgar score in minutes 1 and 5. The need for NICU admission, duration of hospitalization, neonatal respiratory distress syndrome, surfactant requirement, and intubation were lower in the IV betamethasone group. There were no significant differences between the two groups according to necrotizing enterocolitis, intraventricular hemorrhage, and neonatal death.Conclusion: Using IV betamethasone, in cases where there is no enough time to complete the 24-hour betamethasone course due to the possibility of impending delivery, may reduce neonatal complications due to quicker onset of action.
- 13 March 2024
- Published by SCI AND TECH UNIVERSAL INC in Journal of Obstetrics, Gynecology and Cancer Research
- Vol. 9 (2) , 125-130
Open AccessComparison of Intravascular Versus Intramuscular Betamethasone Phosphate on Neonatal Outcomes in the Cases of Imminent Preterm Birth
Background & Objective: Preterm birth is the most important cause of neonatal mortality and morbidity. Finding the best treatment regimen, of antenatal corticosteroids, has been under serious concern. To compare the efficacy of intravascular versus intramuscular betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.Materials & Methods: A double-blind randomized clinical trial was performed on 136 eligible pregnant women with gestational age of 26- 34 weeks and imminent preterm birth (delivery within 24 hours). They were randomly assigned into two groups. Group A received intramuscular betamethasone phosphate, and group B received a similar dose of betamethasone phosphate intravenously. Women were followed up to delivery, and their neonatal outcomes were compared.Results: Women of the two groups (68 women in each group), did not show a significant difference in maternal age, BMI, gravidity and parity, gestational age at the time of admission and delivery, history of miscarriage and assisted reproductive techniques, delivery route, sex and weight of newborns, and Apgar score in minutes 1 and 5. The need for NICU admission, duration of hospitalization, neonatal respiratory distress syndrome, surfactant requirement, and intubation were lower in the IV betamethasone group. There were no significant differences between the two groups according to necrotizing enterocolitis, intraventricular hemorrhage, and neonatal death.Conclusion: Using IV betamethasone, in cases where there is no enough time to complete the 24-hour betamethasone course due to the possibility of impending delivery, may reduce neonatal complications due to quicker onset of action.
- Open Access
- 1 January 2024
- Published by Wiley in Case Reports in Surgery
- Vol. 2024 (1) , 4707627
Pregnancy Following Metabolic–Bariatric Surgery in a Woman With Potential Premature Ovarian Failure: A Case Report
Premature ovarian insufficiency (POI) is associated with decreased ovulation in the precursor stage which leads to ovarian failure in the end stage. Metabolic–bariatric surgery (MBS) can improve women’s reproductive status, including the release of sex hormones, ovulation, and fertilization. Here, we report a spontaneous pregnancy following MBS despite potential ovarian insufficiency. A 38‐year‐old woman with severe obesity underwent three cycles of assisted reproduction that were not successful. Oligomenorrhea ≥ 4 months, laboratory indices, and previous poor ovarian response approved the diagnosis of diminished ovarian reserve and could be considered as the precursor stage of POI. Then a gastric bypass was applied, and a spontaneous pregnancy occurred in the 22nd month after surgery, with 45.80% reduction in body mass index. MBS in women with obesity and idiopathic ovarian insufficiency may increase the chance of spontaneous ovulation and successful pregnancy.
- 1 January 2024
- Published by Wiley in Case Reports in Surgery
- Vol. 2024 (1) , 4707627
Open AccessPregnancy Following Metabolic–Bariatric Surgery in a Woman With Potential Premature Ovarian Failure: A Case Report
Premature ovarian insufficiency (POI) is associated with decreased ovulation in the precursor stage which leads to ovarian failure in the end stage. Metabolic–bariatric surgery (MBS) can improve women’s reproductive status, including the release of sex hormones, ovulation, and fertilization. Here, we report a spontaneous pregnancy following MBS despite potential ovarian insufficiency. A 38‐year‐old woman with severe obesity underwent three cycles of assisted reproduction that were not successful. Oligomenorrhea ≥ 4 months, laboratory indices, and previous poor ovarian response approved the diagnosis of diminished ovarian reserve and could be considered as the precursor stage of POI. Then a gastric bypass was applied, and a spontaneous pregnancy occurred in the 22nd month after surgery, with 45.80% reduction in body mass index. MBS in women with obesity and idiopathic ovarian insufficiency may increase the chance of spontaneous ovulation and successful pregnancy.
- Open Access
- 3 May 2023
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 39 (1) , 2205959
Risk factors of osteoporosis and osteopenia in postmenopausal women based on the L2–L4 BMD T score of the lumbar spine: a study in Iran
To determine the risk factors of osteoporosis and osteopenia of the spine in postmenopausal women.An analytical cross-sectional study was performed on postmenopausal women. The T-score of the lumba...
- 3 May 2023
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 39 (1) , 2205959
Open AccessRisk factors of osteoporosis and osteopenia in postmenopausal women based on the L2–L4 BMD T score of the lumbar spine: a study in Iran
To determine the risk factors of osteoporosis and osteopenia of the spine in postmenopausal women.An analytical cross-sectional study was performed on postmenopausal women. The T-score of the lumba...
- 16 January 2023
- Published by Taylor & Francis in Human Fertility
- Vol. 26 (5) , 1286-1298
Development and psychometric evaluation of a Risky Sexual Behaviour Scale for Married Women (RSBS-MW) in Iran: a mixed-method study
A valid and reliable culture-based scale for the evaluation of risky sexual behaviours for married Iranian women is lacking. This study aimed to develop, and psychometrically test, a risky sexual behaviour scale for married Iranian women. A mixed-method sequential exploratory design was conducted from 2016 to 2020 in Tehran, Iran. First, a qualitative study was employed to define the concept of risky sexual behaviour using 16 semi-structured individual interviews and 10 focus group discussions (n = 100). Then, an item pool was generated, and the scale was developed. Finally, in the quantitative study, the psychometric properties of the scale were evaluated by validity and reliability tests. A maximum likelihood extraction with promax rotation was performed on 400 sexually active married women to assess the construct validity. The six components: (i) ‘quality of sexual relations’; (ii) ‘unusual pleasures in sexual relations’; (iii) ‘sexual coercion’; (iv) ‘verbal violence in sexual relations’; (v) ‘self-care in sexual relations’; and (vi) ‘concealment in sexual relations’ could explain 57.49% of the total observed variance. The findings showed that the 27-item Risky Sexual Behaviour Scale (RSBS-MW) for married women in Iran has excellent internal consistency (α = 0.94) and stability (ICC = 0.98). Health care providers can use it to access risky sexual behaviours in married Iranian women.
- 16 January 2023
- Published by Taylor & Francis in Human Fertility
- Vol. 26 (5) , 1286-1298
Development and psychometric evaluation of a Risky Sexual Behaviour Scale for Married Women (RSBS-MW) in Iran: a mixed-method study
A valid and reliable culture-based scale for the evaluation of risky sexual behaviours for married Iranian women is lacking. This study aimed to develop, and psychometrically test, a risky sexual behaviour scale for married Iranian women. A mixed-method sequential exploratory design was conducted from 2016 to 2020 in Tehran, Iran. First, a qualitative study was employed to define the concept of risky sexual behaviour using 16 semi-structured individual interviews and 10 focus group discussions (n = 100). Then, an item pool was generated, and the scale was developed. Finally, in the quantitative study, the psychometric properties of the scale were evaluated by validity and reliability tests. A maximum likelihood extraction with promax rotation was performed on 400 sexually active married women to assess the construct validity. The six components: (i) ‘quality of sexual relations’; (ii) ‘unusual pleasures in sexual relations’; (iii) ‘sexual coercion’; (iv) ‘verbal violence in sexual relations’; (v) ‘self-care in sexual relations’; and (vi) ‘concealment in sexual relations’ could explain 57.49% of the total observed variance. The findings showed that the 27-item Risky Sexual Behaviour Scale (RSBS-MW) for married women in Iran has excellent internal consistency (α = 0.94) and stability (ICC = 0.98). Health care providers can use it to access risky sexual behaviours in married Iranian women.
- Open Access
- 30 March 2022
- Published by Springer Nature in Research Square
The effect of sildenafil on amniotic fluid volume in cases of borderline oligohydramnios in uncomplicated pregnancies: a randomized clinical trial.
Introduction:Low amniotic fluid volume and oligohydramnios is important issue during pregnancy and is associated with an increase in fetal and neonatal mortality and morbidity. Finding a solution to it can improve fetal and neonatal outcomes.Objective:The purpose of the present study was to evaluate the effect of sildenafil on oligohydramnios in uncomplicated pregnancies.Methods:A placebo-controlled randomized clinical trial was performed on women with oligohydramnios and gestational age of 30 to 37 weeks and singleton pregnancy. The eligible women were randomly assigned into two groups. In the intervention group, 25 mg oral sildenafil was prescribed every 8 hours in conjunction with intravenous hydration therapy with 2 liters isotonic solution (normal saline) infused within 4 hours and in the control group, placebo and hydration therapy similar to the intervention group was prescribed. Amniotic fluid volume was re-evaluated 24 hours after treatment. If at least a 20% increase in amniotic fluid volume was detected by ultrasound, the woman was discharged; otherwise, the above regimen was repeated again for the next 24 hours.Discharged patients continued to take sildenafil or placebo at the same dose and consumption of 2 liters of oral fluids per day up to 37 weeks or delivery each happened earlier. Fetal monitoring was performed using non stress test (NST) twice a week, biophysical profile, and amniotic fluid volume measurement once a week. Amniotic fluid volume and pregnancy and neonatal outcomes were compared in the two groups.Results:One hundred ninety women finished the study. There was no statistically significant difference between the two groups in terms of maternal age, body mass index (BMI), parity, live birth rate, gestational age before the intervention, amniotic fluid index, and the type of pregnancy; spontaneous or using assisted reproductive technology (ART). In undelivered women, after the intervention, the amniotic fluid index was significantly higher in the case group than the control group. The number of women, whose pregnancies continued after the third week of intervention, were higher in the sildenafil group.At the end of the sixth week after intervention, 40 women (42.1%) in the case group continued their pregnancies versus 5 women (5.3%) in the control group (P = 0.001). Cesarean section rate, neonatal intensive care unit (NICU) admission, abnormal cardiotocography, umbilical cord pH less than 7.2, and Apgar score of less than 7 in 5 minutes, were less in the intervention group than the control group. While the mean gestational age at birth and birth weight was higher in the intervention group than the control group. There was no perinatal death in both groups.Abnormal cardiotocography (CTG) (AOR= 6.3, CI95% 2.4-15.1, P< 0.001), cesarean section rate (AOR= 4.2, CI95% 2.1-8.9, P< 0.001), birth weight of less than 2500 gram (AOR= 3.3, CI95% 1.6-6.9, P= 0.001), gestational age at birth of less than 37 weeks (AOR= 3.2, CI95% 1.5-6.9, P= 0.009 ), Apgar score of less than 7 in 5 minutes (AOR= 2.6, CI95% 1.1-6.4, P=0.037), umbilical cord pH of less than 7.2 (AOR= 2.5, CI95% 1.9-6.9, P=0.064), and NICU admission (AOR= 2.5, CI95% 1.1-5.9, P=0.032) were more in the control group.The most common maternal complication in patients was headache (15.8 vs. 7.4%) and headache (12.6 vs. 5.3%) which was more in the intervention group than the control group, but not statistically significant.Conclusion:In pregnant women with oligohydramnios, sildenafil may be associated with better pregnancy outcomes.
- 30 March 2022
- Published by Springer Nature in Research Square
Open AccessThe effect of sildenafil on amniotic fluid volume in cases of borderline oligohydramnios in uncomplicated pregnancies: a randomized clinical trial.
Introduction:Low amniotic fluid volume and oligohydramnios is important issue during pregnancy and is associated with an increase in fetal and neonatal mortality and morbidity. Finding a solution to it can improve fetal and neonatal outcomes.Objective:The purpose of the present study was to evaluate the effect of sildenafil on oligohydramnios in uncomplicated pregnancies.Methods:A placebo-controlled randomized clinical trial was performed on women with oligohydramnios and gestational age of 30 to 37 weeks and singleton pregnancy. The eligible women were randomly assigned into two groups. In the intervention group, 25 mg oral sildenafil was prescribed every 8 hours in conjunction with intravenous hydration therapy with 2 liters isotonic solution (normal saline) infused within 4 hours and in the control group, placebo and hydration therapy similar to the intervention group was prescribed. Amniotic fluid volume was re-evaluated 24 hours after treatment. If at least a 20% increase in amniotic fluid volume was detected by ultrasound, the woman was discharged; otherwise, the above regimen was repeated again for the next 24 hours.Discharged patients continued to take sildenafil or placebo at the same dose and consumption of 2 liters of oral fluids per day up to 37 weeks or delivery each happened earlier. Fetal monitoring was performed using non stress test (NST) twice a week, biophysical profile, and amniotic fluid volume measurement once a week. Amniotic fluid volume and pregnancy and neonatal outcomes were compared in the two groups.Results:One hundred ninety women finished the study. There was no statistically significant difference between the two groups in terms of maternal age, body mass index (BMI), parity, live birth rate, gestational age before the intervention, amniotic fluid index, and the type of pregnancy; spontaneous or using assisted reproductive technology (ART). In undelivered women, after the intervention, the amniotic fluid index was significantly higher in the case group than the control group. The number of women, whose pregnancies continued after the third week of intervention, were higher in the sildenafil group.At the end of the sixth week after intervention, 40 women (42.1%) in the case group continued their pregnancies versus 5 women (5.3%) in the control group (P = 0.001). Cesarean section rate, neonatal intensive care unit (NICU) admission, abnormal cardiotocography, umbilical cord pH less than 7.2, and Apgar score of less than 7 in 5 minutes, were less in the intervention group than the control group. While the mean gestational age at birth and birth weight was higher in the intervention group than the control group. There was no perinatal death in both groups.Abnormal cardiotocography (CTG) (AOR= 6.3, CI95% 2.4-15.1, P< 0.001), cesarean section rate (AOR= 4.2, CI95% 2.1-8.9, P< 0.001), birth weight of less than 2500 gram (AOR= 3.3, CI95% 1.6-6.9, P= 0.001), gestational age at birth of less than 37 weeks (AOR= 3.2, CI95% 1.5-6.9, P= 0.009 ), Apgar score of less than 7 in 5 minutes (AOR= 2.6, CI95% 1.1-6.4, P=0.037), umbilical cord pH of less than 7.2 (AOR= 2.5, CI95% 1.9-6.9, P=0.064), and NICU admission (AOR= 2.5, CI95% 1.1-5.9, P=0.032) were more in the control group.The most common maternal complication in patients was headache (15.8 vs. 7.4%) and headache (12.6 vs. 5.3%) which was more in the intervention group than the control group, but not statistically significant.Conclusion:In pregnant women with oligohydramnios, sildenafil may be associated with better pregnancy outcomes.
- Open Access
- 29 March 2022
- Published by Springer Nature in Research Square
Efficacy comparison of intravascular versus intra muscular betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.
Preterm birth is the most important cause of neonatal mortality and morbidity. Finding the best treatment regimen of antenatal corticosteroids, in order to reduce neonatal complications, has been under serious concern.Objective:The purpose of the present study was to compare the efficacy of intravascular (IV) versus intra muscular (IM) betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.Method:The study was conducted as a double-blind randomized clinical trial. 136 pregnant women with gestational age of 26- 34 weeks of pregnancy and imminent preterm birth (delivery within 24 hours) were randomly assigned into two groups. Group A received intramuscular betamethasone phosphate as a dose of 12 mg, and group B received a similar dose of betamethasone phosphate intravenously. Women were followed up to delivery, and their neonatal outcomes were compared.Results:The women of the two groups (68 women in each group), did not show a significant difference in maternal age, BMI, gravidity and parity, gestational age at the time of admission and delivery, history of miscarriage and assisted reproductive techniques, delivery route, sex and weight of newborns, and Apgar score in minutes 1 and 5. The need for NICU admission, duration of hospitalization, neonatal respiratory distress syndrome, surfactant requirement, and intubation were lower in the IV betamethasone group. There were no significant differences between the two groups according to necrotizing enterocolitis, intraventricular hemorrhage (IVH) and neonatal death.Conclusion:Using IV betamethasone, in cases where there is no enough time to complete the 24-hour betamethasone course due to the possibility of impending delivery, may reduce neonatal complications due to more rapid action.
- 29 March 2022
- Published by Springer Nature in Research Square
Open AccessEfficacy comparison of intravascular versus intra muscular betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.
Preterm birth is the most important cause of neonatal mortality and morbidity. Finding the best treatment regimen of antenatal corticosteroids, in order to reduce neonatal complications, has been under serious concern.Objective:The purpose of the present study was to compare the efficacy of intravascular (IV) versus intra muscular (IM) betamethasone phosphate on neonatal outcomes in the cases of imminent preterm birth.Method:The study was conducted as a double-blind randomized clinical trial. 136 pregnant women with gestational age of 26- 34 weeks of pregnancy and imminent preterm birth (delivery within 24 hours) were randomly assigned into two groups. Group A received intramuscular betamethasone phosphate as a dose of 12 mg, and group B received a similar dose of betamethasone phosphate intravenously. Women were followed up to delivery, and their neonatal outcomes were compared.Results:The women of the two groups (68 women in each group), did not show a significant difference in maternal age, BMI, gravidity and parity, gestational age at the time of admission and delivery, history of miscarriage and assisted reproductive techniques, delivery route, sex and weight of newborns, and Apgar score in minutes 1 and 5. The need for NICU admission, duration of hospitalization, neonatal respiratory distress syndrome, surfactant requirement, and intubation were lower in the IV betamethasone group. There were no significant differences between the two groups according to necrotizing enterocolitis, intraventricular hemorrhage (IVH) and neonatal death.Conclusion:Using IV betamethasone, in cases where there is no enough time to complete the 24-hour betamethasone course due to the possibility of impending delivery, may reduce neonatal complications due to more rapid action.